Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis

被引：0
作者：
Silvia Scriffignano
Fabio Massimo Perrotta
Paola Conigliaro
Mario Ferraioli
Paola Triggianese
Maria Sole Chimenti
Ennio Lubrano
机构：
[1] Della Salute “Vincenzo Tiberio”,Academic Rheumatology Unit, Dipartimento Di Medicina E Scienze
[2] Università Degli Studi del Molise,Rheumatology, Allergology and Clinical Immunology, Dipartimento Di Medicina Dei Sistemi
[3] Università Di Roma Tor Vergata,Inserm
[4] Simone Veil-Santé,Faculté
[5] Université de Versailles-Saint-Quentin-Paris-Saclay,Department of Development and Regeneration, Skeletal Biology and Engineering Research Center
[6] KU Leuven University,undefined
来源：
Rheumatology and Therapy | 2023年 / 10卷
关键词：
Psoriatic arthritis; Outcome measure; Minimal disease activity; Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1785 / 1794
页数：9
相关论文
共 83 条
  • [1] Lubrano E(2019)Psoriatic arthritis, psoriatic disease, or psoriatic syndrome? J Rheumatol 46 1428-1430
  • [2] Scriffignano S(2017)Psoriatic arthritis: state of the art review Clin Med (Lond) 17 65-70
  • [3] Perrotta FM(2019)Sustained very low disease activity and remission in psoriatic arthritis patients Rheumatol Ther 6 521-528
  • [4] Coates LC(2011)The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study Clin Rheumatol 30 1063-1067
  • [5] Helliwell PS(2010)Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis Ann Rheum Dis 69 1441-1447
  • [6] Lubrano E(2010)Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment Ann Rheum Dis 69 48-53
  • [7] Perrotta FM(2013)The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project) Ann Rheum Dis 72 986-991
  • [8] Scriffignano S(2011)Development of a preliminary composite disease activity index in psoriatic arthritis Ann Rheum Dis 70 272-277
  • [9] Scarpa R(2015)Patient's global assessment as an outcome measure for psoriatic arthritis in clinical practice: a surrogate for measuring low disease activity? J Rheumatol 42 2332-2338
  • [10] Atteno M(2019)TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis Expert Rev Clin Immunol 15 1303-1312
123456789